Mimedx (MDXG) Free Cash Flow (2011 - 2026)

Mimedx has disclosed Free Cash Flow across 16 years of filings, most recently posting $1.3 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at $1.3 million, down 73.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $69.4 million (up 5.84% YoY), and the FY2025 annual result was $73.0 million, up 11.5% from the prior year.
• Free Cash Flow came in at $1.3 million for Q1 2026 at Mimedx, down from $24.7 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $29.1 million in Q3 2025 to a low of -$10.3 million in Q1 2022.
• The 5-year median for Free Cash Flow is $7.5 million (2023), against an average of $9.1 million.
• Across the five-year window, Free Cash Flow slumped 383.5% in 2022 and soared 2149.67% in 2023, its largest moves.
• Mimedx's Free Cash Flow stood at $3.6 million in 2022, then surged by 127.82% to $8.3 million in 2023, then jumped by 135.18% to $19.4 million in 2024, then grew by 26.85% to $24.7 million in 2025, then tumbled by 94.69% to $1.3 million in 2026.
• The last three Free Cash Flow figures came in at $1.3 million (Q1 2026), $24.7 million (Q4 2025), and $29.1 million (Q3 2025), per Business Quant data.